Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
For the cannabis industry, 2021 has been a year of mergers and acquisitions. The latest headline-grabbing deal occurred in May, with
Trulieve Cannabis (OTC:TCNNF) announcing it is to acquire fellow multi-state operator (MSO)
Harvest Health & Recreation (OTC:HRVSF) for a cool $2.1 billion.
What Investors Need to Know About Trulieve s $2 1 Billion Deal to Buy Harvest Health fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.
Biggest past-year deals:
Subversive Capital s acquisition of Caliva and Left Coast Ventures ($425 million)
Curaleaf s acquisition of Emmac Life Sciences ($290 million)
Ayr Wellness acquisition of Liberty Health Sciences ($290 million)
Key individuals:
The firm declined to specify the lawyers who led its engagements for Curaleaf, Subversive, and Ayr Wellness.
About:
Stikeman Elliott is one of Canada s largest business law firms. The firm s lawyers worked with Curaleaf on two acquisitions, walked Ayr Wellness through its purchase of Liberty, and represented Canaccord Genuity, the financial advisor to the cannabis SPAC Subversive Capital Acquisition Corp., in its complex merger
From 2015 to 2018, Stikeman regularly worked with Aphria, with The Globe and Mail reporting that the two parted ways after a transaction that drew short-seller scrutiny. The firm declined to comment.
Author Bio
Sushree is a new member of the Fool family, keen on writing about the cannabis and healthcare sector and also has five years of experience writing on real estate, consumer sector, and macroeconomic topics. She holds a bachelor’s degree in business management, specializing in finance, and also a CFA Level 2 candidate. Being a fitness enthusiast and a creative person, when she isn t writing, she is either kick-boxing or painting.
The marijuana industry caught plenty of investor attention last year when it kept soaring amid a global crisis while other sectors were struggling to survive. The drug was deemed an essential item in the U.S. and Canada during the lockdown, leading to higher sales. Sales are on the rise this year, too, and the ongoing wave of state legalization in the U.S. is the icing on the cake. The U.S. cannabis companies, in particular, have outshone their Canadian counterparts. Among these, Florida-based